Boditech Med (XKRX:206640) Risk Assessment

View and export this data going back to 2014. Start your Free Trial

What is Boditech Med Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Boditech Med is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of Boditech Med's Risk Assessment

For the Medical Devices subindustry, Boditech Med's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Boditech Med's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boditech Med's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Boditech Med's Risk Assessment falls into.

Save Embed

;

Save Embed

;

Boditech Med (XKRX:206640) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Boditech Med Risk Assessment Related Terms

Thank you for viewing the detailed overview of Boditech Med's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Boditech Med Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boditech Med Inc (XKRX:206640) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

43, Geodudanji 1-gil, Dongnae-myeon, Gang-won-do, Chuncheon-si, KOR, 200-883

Website

http://www.boditech.co.kr

Boditech Med Inc is a pharmaceutical company which provides diagnostic solutions. It develops, manufactures and distributes products for in-vitro diagnostics and diagnostic reagents. The company is also developing a smart production system that integrates digital technology and IT technology. The firm develops its products for heart disease, cancer, diabetes, hormone, infection, and arthritis.

Boditech Med Headlines

No Headlines